Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
Selection of the optimal peri- and postprocedural antithrombotic regimen in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is a common clinical problem which may pose a challenge to medical practitioners. This systematic review summarizes the updated evide...
Guardado en:
Autores principales: | Marek Koziński, Joanna Rejszel-Baranowska, Elżbieta Młodawska, Jolanta M. Siller-Matula, Anna Tomaszuk-Kazberuk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db48a90338b94bd7b02c1566ce8d177a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Gilda Denise Zielinski, et al.
Publicado: (2020) -
Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
por: Pedro Luis Cepas-Guillen, et al.
Publicado: (2021) -
Eficacia y seguridad del tratamiento anticoagulante oral con antagonistas de vitamina K en pacientes con prótesis valvulares cardíacas
por: Marín,Arnaldo, et al.
Publicado: (2014) -
Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
por: Fuwei Liu, et al.
Publicado: (2021) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
por: Turagam MK, et al.
Publicado: (2015)